Nitrate-augmented myocardial perfusion imaging for assessment of myocardial viability: Recent advances

Nuclear Medicine Communications

Volumn 30, Issue 6, 2009, Pages 415-419

  Yang, Min Fu ^a   Keng, Felix ^b   He, Zuo Xiang ^a  

^a FUWAI HOSPITAL   (China)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Left ventricular dysfunction; Myocardial hibernation; Myocardial viability; Nitrate

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE; GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; TETROFOSMIN; TETROFOSMIN TC 99M; THALLIUM 201; WATER O 15;

CARDIAC PATIENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY VASCULAR RESISTANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG EFFECT; DRUG UPTAKE; EVENT FREE SURVIVAL; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CELL SURVIVAL; CORONARY ARTERY DISEASE; HEART; HUMANS; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; NITRATES; PROGNOSIS;

EID: 67649661996     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832b2ed1     Document Type: Review

References (36)

1. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the hibernating myocardium. J Am Coll Cardiol 1986; 8:1467-1470.
2. Allman KC, Shaw U, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151 -1158.
3. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30:1451-1460.
4. He ZX, Darcourt J, Guignier A, Guignier A, Ferrari E, Bussiere F, er al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993; 34:1472-1477.
5. He ZX, Verani MS, Liu XJ. Nitrate-augmented myocardial imaging for assessment of myocardial viability. J Nucl Cardiol 1995; 2:352-357.
6. so'TI reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial. Circulation 1997; 95:1799-1805.
7. Miyagawa M, Kumano S, Sekiya M, Watanabe K, Hashida K, Shiode M, et al. Assessment of myocardial viability by thallium-201 reinjection imaging with sublingual nitroglycerin. Kaku Igaku 1994; 31:943-950.
8. Oudiz RJ, Smith DE, Pollak AJ, Mena J, Shapiro SM, Ginzton LE, et al. Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium. Am Heart J 1999; 138:369-375.
9. Bisi G, Sciagra R, Santoro GM, Fazzini PR Rest technetium-99 m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994; 24:1282-1289.
10. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P. Effects of nitroglycerin by technetium-99 m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994; 74:843-848.
11. Li ST, Liu XJ, Lu ZL, Zhu XD, Shi RF, Yang YJ, er al. The value of Tc-99 m MIBI SPECT during isosorbide dinitrate infusion in assessment of viable myocardium in patients with myocardial infarction. Ann Nucl Med 1996; 10:13-18.
12. m-tetrofosmin. Nucl Med Commun 1996; 17:669-674.
13. 201TI imaging. Nucl Med Commun 1996; 17:864-871.
14. Bisi G, Sciagra R, Santoro GM, Zerauschek F, Fazzini PR Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med 1994; 35:1274-1278.
15. He ZX, Verani MS. Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used? J Nucl Cardiol 1998; 5:527-532.
16. Fallen EL, Nahmias C, Scheffel A, Coates G, Beanlands R, Garnett ES. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation 1995; 91:1381-1388.
17. Slart RH, Agool A, van Veldhuisen DJ, Dierckx RA, Bax JJ. Nitrate administration increases blood flow in dysfunctional but viable myocardium, leading to improved assessment of myocardial viability: a PET study. J Nucl Med 2006; 47:1307-1311.
18. Tadamura E, Mamede M, Kubo S, Toyoda H, Yamamuro M, lida H, et al. The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT. J Nucl Med 2003; 44:745-751.
19. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008; 117:103-114.
20. 201TI imaging for prognostic evaluation after myocardial infarction and thrombolysis. Circulation 1997; 96: 2932-2937.
21. Sciagra R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V, et al. Prognostic implications of Tc-99 m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000; 36:739-745.
22. Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99 m sestamibi and TI-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol 2002; 9:454-462.
23. Kostkiewicz M, Olszowska M, Przewlocki T, Podolec P, Tracz W. Prognostic value of nitrate enhanced Tc99 m MIBI SPECT study in detecting viable myocardium in patients with coronary artery disease. Int J Cardiovasc Imaging 2003; 19:129-135.
24. He ZX, Yang MF, Liu XJ, Shi RF, Gao RL, Hu SS, et al. Association of myocardial viability on nitrate-augmented technetium-99 m hexakis-2-methoxylisobutyl isonitrile myocardial tomography and intermediate-termn outcome in patients with prior myocardial infarction and left ventricular dysfunction. Am J Cardiol 2003; 92:696-699.
25. Bosevski M, Peovska I, Maksimovic J, Vavlukis M, Meskovska S. Prognostic utility of carotid ultrasound and cardiac SPECT imaging in coronary artery bypass patients. Nucl Med Rev 2006; 9:12-17.
26. Acampa W, Evangelista L, Sorrentino AR, Petretta M, Luongo L, Cuocolo A. Single-photon emission computed tomography after nitrate administration predicts cardiac events in patients with previous myocardial infarction and left ventricular dysfunction. J Card Fail 2007; 13:765-768.
27. Sorrentino AR, Acampa W, Petretta M, Mainolfi C, Salvatore M, Cuocolo A. Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2007; 34:558-562.
28. Evangelista L, Acampa W, Petretta M, Ferro A, Ricci F, Luongo L, et al. Incremental prognostic value of cardiac single-photon emission computed tomography after nitrate administration in patients with ischemic left ventricular dysfunction. J Nucl Cardiol 2009; 16:38-44.
29. Siebelink HM, Blanksma PK, Crijns HJ, Bax JJ, van Boven AJ, Kingma T, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Card/o/2001; 37:81-88.
30. Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med 2001; 42:1730-1736.
31. He W, Acampa W, Mainolfi C, Menna F, Sorrentino AR, Petretta M, ef al. Tc-99 m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET. J Nucl Cardiol 2003; 10:599-606.
32. Giorgetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, et al. Baseline/post-nitrate Tc-99 m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99 m tetrofosmin scintigraphy/FDG PET imaging. J Nucl Cardiol 2004; 11:142-151.
33. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simoneti D, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
34. Giorgetti A, Pingitore A, Favilli B, Kusch A, Lombardi M, Marzullo P. Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postisohemic severe left ventricular dysfunction: new evidence from MRI. J Nucl Med 2005; 46: 1285-1293.
35. Positano V, Pingitore A, Giorgetti A, Favilli B, Santarelli MF, Landini L, et al. A fast and effective method to assess myocardial necrosis by means of contrast magnetic resonance imaging. J Cardiovasc Magn Reson 2005; 7:487-494.
36. Feola M, Rosso GL, Biggi A, Chauvie S, Leonardi G, Margaria F, et al. Correlation between delayed-enhancement magnetic resonance and nitrate myocardial Tc-99 m tetrofosmin scintigraphy in myocardial infarction: a case report. J Med Case Reports 2007; 1:120.